FDA approves Lucentis for treatment of diabetic retinopathy in people with diabetic macular edema
Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic retinopathy (DR) in...